{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T13:55:08Z","timestamp":1794059708602,"version":"4.8.0"},"reference-count":250,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["17-14-01304"],"award-info":[{"award-number":["17-14-01304"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["21-14-00130"],"award-info":[{"award-number":["21-14-00130"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.lfs.2021.120111","type":"journal-article","created":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T10:49:41Z","timestamp":1635677381000},"page":"120111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":505,"special_numbering":"C","title":["Nrf2\/Keap1\/ARE signaling: Towards specific regulation"],"prefix":"10.1016","volume":"291","author":[{"given":"Alexey V.","family":"Ulasov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey A.","family":"Rosenkranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgii P.","family":"Georgiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander S.","family":"Sobolev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2021.120111_bb0005","article-title":"Free radicals and other reactive species in disease","author":"Halliwell","year":"2015","journal-title":"eLS"},{"key":"10.1016\/j.lfs.2021.120111_bb0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/35041687","article-title":"Oxidants, oxidative stress and the biology of ageing","volume":"408","author":"Finkel","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2021.120111_bb0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0955-0674(03)00002-4","article-title":"Oxidant signals and oxidative stress","volume":"15","author":"Finkel","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0020","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrm2256","article-title":"ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis","volume":"8","author":"D'Autreaux","year":"2007","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2021.120111_bb0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism","volume":"39","author":"Hayes","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.lfs.2021.120111_bb0035","doi-asserted-by":"crossref","first-page":"8261","DOI":"10.1073\/pnas.85.21.8261","article-title":"Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis","volume":"85","author":"Talalay","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.120111_bb0040","doi-asserted-by":"crossref","first-page":"9926","DOI":"10.1073\/pnas.91.21.9926","article-title":"Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2\/AP1 repeat of the beta-globin locus control region","volume":"91","author":"Moi","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.120111_bb0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.freeradbiomed.2015.06.006","article-title":"Molecular basis of the Keap1-Nrf2 system","volume":"88","author":"Suzuki","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2021.120111_bb0050","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1101\/gad.13.1.76","article-title":"Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain","volume":"13","author":"Itoh","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.lfs.2021.120111_bb0055","doi-asserted-by":"crossref","first-page":"11908","DOI":"10.1073\/pnas.172398899","article-title":"Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants","volume":"99","author":"Dinkova-Kostova","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.120111_bb0060","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00099-20","article-title":"The molecular mechanisms regulating the KEAP1-NRF2 pathway","volume":"40","author":"Baird","year":"2020","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0065","series-title":"The Keap1-Nrf2 pathway: From mechanism to medical applications","first-page":"125","author":"Baird","year":"2020"},{"key":"10.1016\/j.lfs.2021.120111_bb0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","article-title":"Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases","volume":"18","author":"Cuadrado","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2021.120111_bb0075","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev-pharmtox-010818-021856","article-title":"Modulating NRF2 in disease: timing is everything","volume":"59","author":"Dodson","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.lfs.2021.120111_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22030436","article-title":"Conservation of the Keap1-Nrf2 system: an evolutionary journey through stressful space and time","volume":"22","author":"Fuse","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2021.120111_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/srep27740","article-title":"Rising levels of atmospheric oxygen and evolution of Nrf2","volume":"6","author":"Gacesa","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2021.120111_bb0090","article-title":"Transcriptional regulation by Nrf2","author":"Tonelli","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.lfs.2021.120111_bb0095","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1134\/S0006297917050030","article-title":"Mazes of Nrf2 regulation","volume":"82","author":"Zenkov","year":"2017","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.lfs.2021.120111_bb0100","doi-asserted-by":"crossref","first-page":"10070","DOI":"10.1073\/pnas.0502402102","article-title":"Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2","volume":"102","author":"Eggler","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.120111_bb0105","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1128\/MCB.01191-13","article-title":"Kinetic, thermodynamic, and structural characterizations of the association between Nrf2-DLGex degron and Keap1","volume":"34","author":"Fukutomi","year":"2014","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0110","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1038\/sj.emboj.7601243","article-title":"Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling","volume":"25","author":"Lo","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.lfs.2021.120111_bb0115","doi-asserted-by":"crossref","first-page":"24756","DOI":"10.1074\/jbc.M601119200","article-title":"Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a \"tethering\" mechanism: a two-site interaction model for the Nrf2-Keap1 complex","volume":"281","author":"McMahon","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb0120","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s42003-021-02100-6","article-title":"Molecular basis for the disruption of Keap1-Nrf2 interaction via Hinge & Latch mechanism","volume":"4","author":"Horie","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0125","doi-asserted-by":"crossref","first-page":"10941","DOI":"10.1128\/MCB.24.24.10941-10953.2004","article-title":"Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex","volume":"24","author":"Zhang","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0130","doi-asserted-by":"crossref","first-page":"10895","DOI":"10.1128\/MCB.25.24.10895-10906.2005","article-title":"The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation","volume":"25","author":"Nioi","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0135","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1046\/j.1365-2443.2001.00469.x","article-title":"Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription","volume":"6","author":"Katoh","year":"2001","journal-title":"Genes Cells"},{"key":"10.1016\/j.lfs.2021.120111_bb0140","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1128\/MCB.01639-08","article-title":"Acetylation of Nrf2 by p300\/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response","volume":"29","author":"Sun","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2015.04.029","article-title":"Structural and functional characterization of Nrf2 degradation by glycogen synthase kinase 3\/beta-TrCP","volume":"88","author":"Cuadrado","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2021.120111_bb0150","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1158\/0008-5472.CAN-12-3386","article-title":"RXRalpha inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2","volume":"73","author":"Wang","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2021.120111_bb0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.freeradbiomed.2015.05.034","article-title":"Structural basis of Keap1 interactions with Nrf2","volume":"88","author":"Canning","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2021.120111_bb0160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4062\/biomolther.2017.195","article-title":"Dysregulation of NRF2 in cancer: from molecular mechanisms to therapeutic opportunities","volume":"26","author":"Jung","year":"2018","journal-title":"Biomol. Ther. (Seoul.)"},{"key":"10.1016\/j.lfs.2021.120111_bb0165","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.yexcr.2008.02.014","article-title":"PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria","volume":"314","author":"Lo","year":"2008","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.lfs.2021.120111_bb0170","doi-asserted-by":"crossref","first-page":"8984","DOI":"10.1074\/jbc.M709040200","article-title":"Multiple nuclear localization signals function in the nuclear import of the transcription factor Nrf2","volume":"283","author":"Theodore","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb0175","doi-asserted-by":"crossref","first-page":"28430","DOI":"10.1074\/jbc.M410601200","article-title":"Nrf2 possesses a redox-insensitive nuclear export signal overlapping with the leucine zipper motif","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb0180","doi-asserted-by":"crossref","first-page":"27251","DOI":"10.1074\/jbc.M602746200","article-title":"Nrf2 possesses a redox-sensitive nuclear exporting signal in the Neh5 transactivation domain","volume":"281","author":"Li","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb0185","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.bbamcr.2008.05.024","article-title":"Heterodimerization with small maf proteins enhances nuclear retention of Nrf2 via masking the NESzip motif","volume":"1783","author":"Li","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2021.120111_bb0190","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.gene.2016.04.040","article-title":"BACH1, the master regulator gene: a novel candidate target for cancer therapy","volume":"588","author":"Davudian","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.lfs.2021.120111_bb0195","doi-asserted-by":"crossref","first-page":"16891","DOI":"10.1074\/jbc.M500166200","article-title":"Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants","volume":"280","author":"Dhakshinamoorthy","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb0200","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1042\/BJ20110526","article-title":"Novel insights into the regulation of antioxidant-response-element-mediated gene expression by electrophiles: induction of the transcriptional repressor BACH1 by Nrf2","volume":"440","author":"Jyrkkanen","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.lfs.2021.120111_bb0205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/iub.314","article-title":"C-myc is a Nrf2-interacting protein that negatively regulates phase II genes through their electrophile responsive elements","volume":"62","author":"Levy","year":"2010","journal-title":"IUBMBLife"},{"key":"10.1016\/j.lfs.2021.120111_bb0210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.freeradbiomed.2015.06.013","article-title":"Epigenetic regulation of Keap1-Nrf2 signaling","volume":"88","author":"Guo","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2021.120111_bb0215","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/BST20150011","article-title":"Dual regulation of transcription factor Nrf2 by Keap1 and by the combined actions of beta-TrCP and GSK-3","volume":"43","author":"Hayes","year":"2015","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.lfs.2021.120111_bb0220","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pharep.2016.12.011","article-title":"The Nrf2-ARE signaling pathway: an update on its regulation and possible role in cancer prevention and treatment","volume":"69","author":"Krajka-Kuzniak","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.lfs.2021.120111_bb0225","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","article-title":"NRF2 and the hallmarks of cancer","volume":"34","author":"Rojo","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lfs.2021.120111_bb0230","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1128\/MCB.01080-08","article-title":"The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds","volume":"29","author":"Kobayashi","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0235","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1128\/MCB.01704-07","article-title":"Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity","volume":"28","author":"Yamamoto","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0240","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00660-16","article-title":"p97 negatively regulates NRF2 by extracting ubiquitylated NRF2 from the KEAP1-CUL3 E3 complex","volume":"37","author":"Tao","year":"2017","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0245","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.freeradbiomed.2015.04.036","article-title":"The emerging role of Nrf2 in mitochondrial function","volume":"88","author":"Dinkova-Kostova","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2021.120111_bb0250","doi-asserted-by":"crossref","first-page":"15259","DOI":"10.1073\/pnas.1305687110","article-title":"Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex","volume":"110","author":"Baird","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.120111_bb0255","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.biotechadv.2014.03.004","article-title":"Monitoring Keap1-Nrf2 interactions in single live cells","volume":"32","author":"Baird","year":"2014","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.lfs.2021.120111_bb0260","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1128\/MCB.00389-16","article-title":"Absolute amounts and status of the Nrf2-Keap1-Cul3 complex within cells","volume":"36","author":"Iso","year":"2016","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0265","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1128\/MCB.05036-11","article-title":"KPNA6 (Importin {alpha}7)-mediated nuclear import of Keap1 represses the Nrf2-dependent antioxidant response","volume":"31","author":"Sun","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0270","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1128\/MCB.00630-07","article-title":"Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2","volume":"27","author":"Sun","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0275","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1128\/MCB.25.11.4501-4513.2005","article-title":"Keap1 regulates the oxidation-sensitive shuttling of Nrf2 into and out of the nucleus via a Crm1-dependent nuclear export mechanism","volume":"25","author":"Velichkova","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0280","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1128\/MCB.25.3.1089-1099.2005","article-title":"Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes","volume":"25","author":"Karapetian","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0285","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.freeradbiomed.2009.07.035","article-title":"Nrf 2:INrf2 (Keap1) signaling in oxidative stress","volume":"47","author":"Kaspar","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2021.120111_bb0290","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2013.12.028","article-title":"Progeria: a paradigm for translational medicine","volume":"156","author":"Gordon","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2021.120111_bb0295","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/acel.12300","article-title":"Sulforaphane enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts","volume":"14","author":"Gabriel","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.lfs.2021.120111_bb0300","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.cell.2016.05.017","article-title":"Repression of the antioxidant NRF2 pathway in premature aging","volume":"165","author":"Kubben","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2021.120111_bb0305","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.arr.2018.06.003","article-title":"Nrf2: molecular and epigenetic regulation during aging","volume":"47","author":"Silva-Palacios","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.lfs.2021.120111_bb0310","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6635460","article-title":"The Keap1-Nrf2 system: a mediator between oxidative stress and aging","author":"Yu","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2021.120111_bb0315","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1073\/pnas.1417566112","article-title":"Regulation of Nrf2 signaling and longevity in naturally long-lived rodents","volume":"112","author":"Lewis","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.120111_bb0320","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.devcel.2011.09.008","article-title":"Animal transcription networks as highly connected, quantitative continua","volume":"21","author":"Biggin","year":"2011","journal-title":"Dev. Cell"},{"key":"10.1016\/j.lfs.2021.120111_bb0325","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2443.2003.00640.x","article-title":"Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles","volume":"8","author":"Itoh","year":"2003","journal-title":"Genes Cells"},{"key":"10.1016\/j.lfs.2021.120111_bb0330","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/MCB.24.16.7130-7139.2004","article-title":"Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2","volume":"24","author":"Kobayashi","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0335","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1074\/jbc.M207293200","article-title":"Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome","volume":"278","author":"Nguyen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb0340","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1074\/jbc.M209195200","article-title":"Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium","volume":"278","author":"Stewart","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb0345","doi-asserted-by":"crossref","first-page":"13561","DOI":"10.1073\/pnas.1121572109","article-title":"Keap1 degradation by autophagy for the maintenance of redox homeostasis","volume":"109","author":"Taguchi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.120111_bb0350","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/cdd.2010.114","article-title":"INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis","volume":"18","author":"Niture","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2021.120111_bb0355","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.cellsig.2010.06.004","article-title":"Suppression of NF-kappaB signaling by KEAP1 regulation of IKKbeta activity through autophagic degradation and inhibition of phosphorylation","volume":"22","author":"Kim","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.lfs.2021.120111_bb0360","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.phrs.2018.06.013","article-title":"Canonical and non-canonical mechanisms of Nrf2 activation","volume":"134","author":"Silva-Islas","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2021.120111_bb0365","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.freeradbiomed.2020.03.023","article-title":"Beyond repression of Nrf2: an update on Keap1","volume":"157","author":"Kopacz","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2021.120111_bb0370","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1021\/acs.jpcb.8b03295","article-title":"Prediction of binding energy of Keap1 interaction motifs in the Nrf2 antioxidant pathway and design of potential high-affinity peptides","volume":"122","author":"Karttunen","year":"2018","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.lfs.2021.120111_bb0375","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s40139-017-0131-0","article-title":"Non-canonical activation of NRF2: new insights and its relevance to disease","volume":"5","author":"Dodson","year":"2017","journal-title":"Curr. Pathobiol. Rep."},{"key":"10.1016\/j.lfs.2021.120111_bb0380","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.molcel.2013.08.003","article-title":"Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy","volume":"51","author":"Ichimura","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.lfs.2021.120111_bb0385","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ncb2021","article-title":"The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1","volume":"12","author":"Komatsu","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0390","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.molcel.2009.04.029","article-title":"Direct interaction between Nrf2 and p21(Cip1\/WAF1) upregulates the Nrf2-mediated antioxidant response","volume":"34","author":"Chen","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.lfs.2021.120111_bb0395","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1158\/0008-5472.CAN-16-2055","article-title":"p21(WAF1) mediates cell-cycle inhibition, relevant to cancer suppression and therapy","volume":"76","author":"El-Deiry","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2021.120111_bb0400","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.dnarep.2016.04.008","article-title":"Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage","volume":"42","author":"Karimian","year":"2016","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.lfs.2021.120111_bb0405","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1128\/MCB.00248-10","article-title":"A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62","volume":"30","author":"Lau","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0410","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1107\/S1744309108004995","article-title":"Structural analysis of the complex of Keap1 with a prothymosin alpha peptide","volume":"64","author":"Padmanabhan","year":"2008","journal-title":"Acta Crystallogr.Sect. F. Struct. Biol. Cryst. Commun."},{"key":"10.1016\/j.lfs.2021.120111_bb0415","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1158\/0008-5472.CAN-12-4400","article-title":"Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination","volume":"73","author":"Hast","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2021.120111_bb0420","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1158\/0008-5472.CAN-16-2204","article-title":"NRF2 induction supporting breast cancer cell survival is enabled by oxidative stress-induced DPP3-KEAP1 interaction","volume":"77","author":"Lu","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2021.120111_bb0425","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1074\/jbc.M111.316471","article-title":"Wilms tumor gene on X chromosome (WTX) inhibits degradation of NRF2 protein through competitive binding to KEAP1 protein","volume":"287","author":"Camp","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb0430","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1128\/MCB.06271-11","article-title":"PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function","volume":"32","author":"Ma","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0435","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ccell.2017.09.008","article-title":"iASPP is an antioxidative factor and drives cancer growth and drug resistance by competing with Nrf2 for Keap1 binding","volume":"32","author":"Ge","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lfs.2021.120111_bb0440","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1038\/onc.2017.161","article-title":"CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells","volume":"36","author":"Wang","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2021.120111_bb0445","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.20151208","article-title":"Gankyrin has an antioxidative role through the feedback regulation of Nrf2 in hepatocellular carcinoma","volume":"213","author":"Yang","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2021.120111_bb0450","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1038\/s41388-019-0698-5","article-title":"The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis","volume":"38","author":"Zhou","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2021.120111_bb0455","doi-asserted-by":"crossref","first-page":"23719","DOI":"10.1074\/jbc.M116.729418","article-title":"Identification and characterization of MCM3 as a kelch-like ECH-associated protein 1 (KEAP1) substrate","volume":"291","author":"Mulvaney","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb0460","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ebiom.2019.06.022","article-title":"FAM129B, an antioxidative protein, reduces chemosensitivity by competing with Nrf2 for Keap1 binding","volume":"45","author":"Cheng","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.lfs.2021.120111_bb0465","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.30962","article-title":"RPB5-mediating protein promotes cholangiocarcinoma tumorigenesis and drug resistance by competing with NRF2 for KEAP1 binding","volume":"71","author":"Wan","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2021.120111_bb0470","doi-asserted-by":"crossref","first-page":"10228","DOI":"10.1093\/nar\/gks827","article-title":"Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks","volume":"40","author":"Hirotsu","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2021.120111_bb0475","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1093\/nar\/gks409","article-title":"Identification of novel NRF2-regulated genes by ChIP-seq: influence on retinoid X receptor alpha","volume":"40","author":"Chorley","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2021.120111_bb0480","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.freeradbiomed.2011.10.453","article-title":"Nuclear factor erythroid-derived factor 2-related factor 2 regulates transcription of CCAAT\/enhancer-binding protein beta during adipogenesis","volume":"52","author":"Hou","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2021.120111_bb0485","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1128\/MCB.00915-07","article-title":"NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis","volume":"27","author":"Shin","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0490","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.1093\/nar\/gkq212","article-title":"Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-seq profiling and network analysis","volume":"38","author":"Malhotra","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2021.120111_bb0495","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2000762","article-title":"Regulation of notch1 signaling by nrf2: implications for tissue regeneration","volume":"3","author":"Wakabayashi","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.lfs.2021.120111_bb0500","doi-asserted-by":"crossref","first-page":"36865","DOI":"10.1074\/jbc.M110.175802","article-title":"Hsp90 interaction with INrf2(Keap1) mediates stress-induced Nrf2 activation","volume":"285","author":"Niture","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb0505","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.molcel.2009.07.025","article-title":"KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta","volume":"36","author":"Lee","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.lfs.2021.120111_bb0510","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.abb.2010.12.034","article-title":"Transcription factor Nrf2 maintains the basal expression of Mdm2: an implication of the regulation of p53 signaling by Nrf2","volume":"507","author":"You","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.lfs.2021.120111_bb0515","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2015.07.147","article-title":"Nrf2\u2013a therapeutic target for the treatment of neurodegenerative diseases","volume":"88","author":"Johnson","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2021.120111_bb0520","doi-asserted-by":"crossref","DOI":"10.3390\/diseases4040034","article-title":"The role of the Nrf2\/ARE antioxidant system in preventing cardiovascular diseases","volume":"4","author":"Smith","year":"2016","journal-title":"Diseases"},{"key":"10.1016\/j.lfs.2021.120111_bb0525","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1113\/jphysiol.2011.210294","article-title":"Targeting the Nrf2-Keap1 antioxidant defence pathway for neurovascular protection in stroke","volume":"589","author":"Alfieri","year":"2011","journal-title":"J. Physiol."},{"key":"10.1016\/j.lfs.2021.120111_bb0530","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1152\/physiolgenomics.00041.2017","article-title":"Nrf2 at the heart of oxidative stress and cardiac protection","volume":"50","author":"Chen","year":"2018","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.lfs.2021.120111_bb0535","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bcp.2018.04.010","article-title":"Nrf2 as a therapeutic target for rheumatic diseases","volume":"152","author":"Ferrandiz","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120111_bb0540","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/pr.117.014753","article-title":"Transcription factor NRF2 as a therapeutic target for chronic diseases: a systems medicine approach","volume":"70","author":"Cuadrado","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.lfs.2021.120111_bb0545","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/1743-422X-10-251","article-title":"Oxidative stress and hepatitis C virus","volume":"10","author":"Paracha","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.lfs.2021.120111_bb0550","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8910396","article-title":"Oxidative stress during HIV infection: mechanisms and consequences","author":"Ivanov","year":"2016","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.lfs.2021.120111_bb0555","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.arcmed.2020.04.019","article-title":"Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection","volume":"51","author":"Delgado-Roche","year":"2020","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.lfs.2021.120111_bb0560","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3233\/JAD-161032","article-title":"Meta-analysis of Parkinson's disease and Alzheimer's disease revealed commonly impaired pathways and dysregulation of NRF2-dependent genes","volume":"56","author":"Wang","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.lfs.2021.120111_bb0565","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2350-11-36","article-title":"Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease","volume":"11","author":"von Otter","year":"2010","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.lfs.2021.120111_bb0570","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.18632\/oncotarget.7353","article-title":"NFE2L2 variations reduce antioxidant response in patients with parkinson disease","volume":"7","author":"Gui","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2021.120111_bb0575","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12881-014-0131-4","article-title":"Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study","volume":"15","author":"von Otter","year":"2014","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.lfs.2021.120111_bb0580","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.mad.2009.12.007","article-title":"Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract","volume":"131","author":"von Otter","year":"2010","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.lfs.2021.120111_bb0585","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/21678421.2013.839708","article-title":"Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis","volume":"15","author":"Bergstrom","year":"2014","journal-title":"Amyotroph. Lateral. Scler. Frontotemporal. Degener."},{"key":"10.1016\/j.lfs.2021.120111_bb0590","first-page":"394","article-title":"Nrf2 gene promoter polymorphism is associated with ulcerative colitis in a japanese population","volume":"55","author":"Arisawa","year":"2008","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.lfs.2021.120111_bb0595","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neuro.2006.07.019","article-title":"In vivo modulation of the parkinsonian phenotype by Nrf2","volume":"27","author":"Burton","year":"2006","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.lfs.2021.120111_bb0600","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1073\/pnas.0813361106","article-title":"Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.120111_bb0605","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1089\/ars.2010.3731","article-title":"Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism","volume":"14","author":"Jazwa","year":"2011","journal-title":"Antioxid. Redox.Signal."},{"key":"10.1016\/j.lfs.2021.120111_bb0610","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neuro.2012.01.015","article-title":"Activation of the Nrf2-ARE pathway by siRNA knockdown of Keap1 reduces oxidative stress and provides partial protection from MPTP-mediated neurotoxicity","volume":"33","author":"Williamson","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.lfs.2021.120111_bb0615","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/nen.0b013e31802d6da9","article-title":"Expression of Nrf2 in neurodegenerative diseases","volume":"66","author":"Ramsey","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.lfs.2021.120111_bb0620","doi-asserted-by":"crossref","first-page":"16505","DOI":"10.1073\/pnas.0908397106","article-title":"Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease","volume":"106","author":"Kanninen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.120111_bb0625","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.freeradbiomed.2013.11.014","article-title":"Antisense oligonucleotide against GSK-3beta in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: involvement of transcription factor Nrf2 and implications for alzheimer disease","volume":"67","author":"Farr","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2021.120111_bb0630","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/thx.2007.091181","article-title":"Altered Nrf2\/Keap1-Bach1 equilibrium in pulmonary emphysema","volume":"63","author":"Goven","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.lfs.2021.120111_bb0635","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1165\/rcmb.2007-0424OC","article-title":"Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease","volume":"39","author":"Suzuki","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.lfs.2021.120111_rf202110291840066761","volume":"3","author":"Harvey","year":"2011"},{"key":"10.1016\/j.lfs.2021.120111_rf202110291840067104","volume":"3","author":"Harvey","year":"2011"},{"key":"10.1016\/j.lfs.2021.120111_bb0645","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/med.21396","article-title":"The Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update","volume":"36","author":"Lu","year":"2016","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.lfs.2021.120111_bb0650","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.freeradbiomed.2011.03.027","article-title":"Neuroprotective effect of Nrf2\/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis","volume":"51","author":"Neymotin","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2021.120111_bb0655","series-title":"Nrf2 and Parkinson's Disease","author":"Todorovic","year":"2016"},{"key":"10.1016\/j.lfs.2021.120111_bb0660","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pharmthera.2015.11.003","article-title":"Nrf2-ARE pathway: an emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases","volume":"157","author":"Buendia","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2021.120111_bb0665","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1111\/febs.14379","article-title":"The role of Nrf2 signaling in counteracting neurodegenerative diseases","volume":"285","author":"Dinkova-Kostova","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.lfs.2021.120111_bb0670","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/157488912803252023","article-title":"The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases","volume":"7","author":"Joshi","year":"2012","journal-title":"Recent Pat. CNS Drug. Discov."},{"key":"10.1016\/j.lfs.2021.120111_bb0675","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00109-021-02071-5","article-title":"Nrf2 as a potential target for Parkinson's disease therapy","volume":"99","author":"Niu","year":"2021","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.lfs.2021.120111_bb0680","doi-asserted-by":"crossref","first-page":"6208067","DOI":"10.1155\/2018\/6208067","article-title":"Therapeutic modulation of virus-induced oxidative stress via the Nrf2-dependent antioxidative pathway","volume":"2018","author":"Lee","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2021.120111_bb0685","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1002\/jcb.26897","article-title":"The role of Nrf2 transcription factor in viral infection","volume":"119","author":"Ramezani","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.lfs.2021.120111_bb0690","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3390\/antiox10091491","article-title":"NRF2 in viral infection","volume":"10","author":"Herengt","year":"2021","journal-title":"Antioxidants. (Basel)"},{"key":"10.1016\/j.lfs.2021.120111_bb0695","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1465-9921-13-43","article-title":"Nrf2 protects human alveolar epithelial cells against injury induced by influenza A virus","volume":"13","author":"Kosmider","year":"2012","journal-title":"Respir. Res."},{"key":"10.1016\/j.lfs.2021.120111_bb0700","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.32303","article-title":"Extreme heterogeneity of influenza virus infection in single cells","volume":"7","author":"Russell","year":"2018","journal-title":"elife"},{"key":"10.1016\/j.lfs.2021.120111_bb0705","doi-asserted-by":"crossref","first-page":"32000","DOI":"10.1038\/srep32000","article-title":"Activation of Nrf2 by the dengue virus causes an increase in CLEC5A, which enhances TNF-alpha production by mononuclear phagocytes","volume":"6","author":"Cheng","year":"2016","journal-title":"Sci Rep."},{"key":"10.1016\/j.lfs.2021.120111_bb0710","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01551-20","article-title":"Dengue Virus Targets Nrf2 for NS2B3-Mediated Degradation Leading to Enhanced Oxidative Stress and Viral Replication","volume":"94","author":"Ferrari","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.lfs.2021.120111_bb0715","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.freeradbiomed.2015.05.043","article-title":"Respiratory syncytial virus infection down-regulates antioxidant enzyme expression by triggering deacetylation-proteasomal degradation of Nrf2","volume":"88","author":"Komaravelli","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2021.120111_bb0720","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.freeradbiomed.2017.10.380","article-title":"Respiratory syncytial virus induces NRF2 degradation through a promyelocytic leukemia protein - ring finger protein 4 dependent pathway","volume":"113","author":"Komaravelli","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2021.120111_bb0725","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1164\/rccm.200804-535OC","article-title":"Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease","volume":"179","author":"Cho","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2021.120111_bb0730","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.antiviral.2018.11.009","article-title":"RA-839, a selective agonist of Nrf2\/ARE pathway, exerts potent anti-rotaviral efficacy in vitro","volume":"161","author":"Patra","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.lfs.2021.120111_bb0735","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1038\/s41467-019-12894-z","article-title":"Single-cell RNA-sequencing of herpes simplex virus 1-infected cells connects NRF2 activation to an antiviral program","volume":"10","author":"Wyler","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2021.120111_bb0740","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184659","article-title":"Effect of hepatitis viruses on the Nrf2\/Keap1-signaling pathway and its impact on viral replication and pathogenesis","volume":"20","author":"Bender","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2021.120111_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110102","article-title":"SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression","volume":"143","author":"Cecchini","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.lfs.2021.120111_bb0750","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s10930-020-09935-8","article-title":"Role of oxidative stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) infection: a review","volume":"39","author":"Suhail","year":"2020","journal-title":"Protein J."},{"key":"10.1016\/j.lfs.2021.120111_bb0755","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.exger.2015.11.004","article-title":"Sulforaphane induces Nrf2 target genes and attenuates inflammatory gene expression in microglia from brain of young adult and aged mice","volume":"73","author":"Townsend","year":"2016","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.lfs.2021.120111_bb0760","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.ymthe.2017.04.022","article-title":"Activation of Nrf2 signaling augments vesicular stomatitis virus oncolysis via autophagy-driven suppression of antiviral immunity","volume":"25","author":"Olagnier","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.lfs.2021.120111_bb0765","doi-asserted-by":"crossref","first-page":"11624","DOI":"10.1038\/ncomms11624","article-title":"Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2021.120111_bb0770","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41577-021-00553-8","article-title":"Is IL-6 a key cytokine target for therapy in COVID-19?","volume":"21","author":"Jones","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2021.120111_bb0775","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1038\/s41467-020-18764-3","article-title":"SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate","volume":"11","author":"Olagnier","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2021.120111_bb0780","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1210\/en.2017-00752","article-title":"Nrf2 deficiency upregulates intrarenal angiotensin-converting Enzyme-2 and angiotensin 1\u20137 receptor expression and attenuates hypertension and nephropathy in diabetic mice","volume":"159","author":"Zhao","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.lfs.2021.120111_bb0785","first-page":"467","volume":"13","author":"Petry","year":"2010","journal-title":"Antioxid. RedoxSignal."},{"key":"10.1016\/j.lfs.2021.120111_bb0790","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.RES.74.6.1141","article-title":"Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells","volume":"74","author":"Griendling","year":"1994","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2021.120111_bb0795","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ajpath.2016.11.011","article-title":"Modulation of antiviral immunity by heme Oxygenase-1","volume":"187","author":"Espinoza","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2021.120111_bb0800","article-title":"Potential cytoprotective activity of ozone therapy in SARS-CoV-2\/COVID-19","volume":"9","author":"Martinez-Sanchez","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.lfs.2021.120111_bb0805","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrc3278","article-title":"NRF2 and cancer: the good, the bad and the importance of context","volume":"12","author":"Sporn","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2021.120111_bb0810","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fonc.2017.00085","article-title":"The KEAP1-NRF2 system in cancer","volume":"7","author":"Taguchi","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2021.120111_bb0815","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/carcin\/bgp231","article-title":"Nrf2: friend or foe for chemoprevention?","volume":"31","author":"Kensler","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lfs.2021.120111_bb0820","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1089\/ars.2010.3221","article-title":"Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway","volume":"13","author":"Hayes","year":"2010","journal-title":"Antioxid. Redox.Signal."},{"key":"10.1016\/j.lfs.2021.120111_bb0825","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1089\/ars.2010.3276","article-title":"Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory","volume":"13","author":"Hu","year":"2010","journal-title":"Antioxid. Redox.Signal."},{"key":"10.1016\/j.lfs.2021.120111_bb0830","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.18632\/oncotarget.19838","article-title":"The prognostic value of NRF2 in solid tumor patients: a meta-analysis","volume":"9","author":"Wang","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2021.120111_bb0835","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature10189","article-title":"Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis","volume":"475","author":"DeNicola","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2021.120111_bb0840","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/path.2653","article-title":"Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin","volume":"220","author":"Kim","year":"2010","journal-title":"J. Pathol."},{"key":"10.1016\/j.lfs.2021.120111_bb0845","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.molcel.2006.01.013","article-title":"Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer","volume":"21","author":"Padmanabhan","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.lfs.2021.120111_bb0850","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030420","article-title":"Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer","volume":"3","author":"Singh","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.lfs.2021.120111_bb0855","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbrc.2008.06.004","article-title":"Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues","volume":"373","author":"Wang","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2021.120111_bb0860","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ccr.2011.09.006","article-title":"Renal cyst formation in Fh1-deficient mice is independent of the Hif\/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling","volume":"20","author":"Adam","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lfs.2021.120111_bb0865","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nbt0513-373a","article-title":"Second oral MS drug wins FDA nod","volume":"31","author":"Sheridan","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.lfs.2021.120111_bb0870","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cbpa.2010.12.009","article-title":"Small molecule modulators of antioxidant response pathway","volume":"15","author":"Hur","year":"2011","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb0875","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/med.21257","article-title":"Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents","volume":"32","author":"Magesh","year":"2012","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.lfs.2021.120111_bb0880","doi-asserted-by":"crossref","first-page":"18838","DOI":"10.1073\/pnas.1007387107","article-title":"Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals","volume":"107","author":"McMahon","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.120111_bb0885","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1021\/jm400224q","article-title":"Keap calm, and carry on covalently","volume":"56","author":"Wilson","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb0890","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1742-2094-9-163","article-title":"Effects of dimethyl fumarate on neuroprotection and immunomodulation","volume":"9","author":"Albrecht","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.lfs.2021.120111_bb0895","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1177\/1060028013509232","article-title":"Dimethyl fumarate (Tecfidera): a new oral agent for multiple sclerosis","volume":"47","author":"Venci","year":"2013","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.lfs.2021.120111_bb0900","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.4049\/jimmunol.1101868","article-title":"Dimethyl fumarate, an immune modulator and inducer of the antioxidant response, suppresses HIV replication and macrophage-mediated neurotoxicity: a novel candidate for HIV neuroprotection","volume":"187","author":"Cross","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2021.120111_bb0905","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005581","article-title":"Sulforaphane inhibits HIV infection of macrophages through Nrf2","volume":"12","author":"Furuya","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.lfs.2021.120111_bb0910","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.freeradbiomed.2011.04.027","article-title":"Nrf2 expression modifies influenza a entry and replication in nasal epithelial cells","volume":"51","author":"Kesic","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2021.120111_bb0915","article-title":"Sulforaphane suppresses hepatitis C virus replication by up-regulating heme Oxygenase-1 expression through PI3K\/Nrf2 pathway","volume":"11","author":"Yu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2021.120111_bb0920","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036216","article-title":"Modulation of experimental herpes encephalitis-associated neurotoxicity through sulforaphane treatment","volume":"7","author":"Schachtele","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2021.120111_bb0925","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022862","article-title":"Proteomic analysis shows synthetic oleanane triterpenoid binds to mTOR","volume":"6","author":"Yore","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2021.120111_bb0930","doi-asserted-by":"crossref","first-page":"rs10","DOI":"10.1126\/scisignal.aaf7694","article-title":"Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells","volume":"9","author":"Blewett","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.lfs.2021.120111_bb0935","doi-asserted-by":"crossref","first-page":"9943","DOI":"10.1002\/jcp.27930","article-title":"Dimethyl fumarate: regulatory effects on the immune system in the treatment of multiple sclerosis","volume":"234","author":"Hosseini","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2021.120111_bb0940","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1073\/pnas.1603907113","article-title":"Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2","volume":"113","author":"Schulze-Topphoff","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.120111_bb0945","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1158\/1940-6207.CAPR-09-0250","article-title":"Sulforaphane inhibits constitutive and interleukin-6-induced activation of signal transducer and activator of transcription 3 in prostate cancer cells","volume":"3","author":"Hahm","year":"2010","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.lfs.2021.120111_bb0950","doi-asserted-by":"crossref","first-page":"32008","DOI":"10.1074\/jbc.M104794200","article-title":"Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms","volume":"276","author":"Heiss","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb0955","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/513481a","article-title":"Chemistry: chemical con artists foil drug discovery","volume":"513","author":"Baell","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2021.120111_bb0960","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.bmcl.2015.04.019","article-title":"Non-electrophilic modulators of the canonical Keap1\/Nrf2 pathway","volume":"25","author":"Richardson","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.lfs.2021.120111_bb0965","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.4155\/fmc.14.60","article-title":"The essential roles of chemistry in high-throughput screening triage","volume":"6","author":"Dahlin","year":"2014","journal-title":"FutureMed. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb0970","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1039\/C6MD00500D","article-title":"Small molecules inhibiting Keap1-Nrf2 protein-protein interactions: a novel approach to activate Nrf2 function","volume":"8","author":"Zhuang","year":"2017","journal-title":"Med. Chem. Comm."},{"key":"10.1016\/j.lfs.2021.120111_bb0975","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1042\/bj20021619","article-title":"Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element","volume":"371","author":"Balogun","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.lfs.2021.120111_bb0980","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/mnfr.201200540","article-title":"Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway","volume":"57","author":"Soetikno","year":"2013","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.lfs.2021.120111_bb0985","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/biof.5520170112","article-title":"Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs?","volume":"17","author":"Coles","year":"2003","journal-title":"Biofactors"},{"key":"10.1016\/j.lfs.2021.120111_bb0990","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0006-2952(03)00504-5","article-title":"The changing faces of glutathione, a cellular protagonist","volume":"66","author":"Pompella","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120111_bb0995","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0074-7696(08)60166-7","article-title":"The glutathione status of cells","volume":"54","author":"Kosower","year":"1978","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.lfs.2021.120111_bb1000","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.freeradbiomed.2013.07.022","article-title":"Nrf2\/ARE-mediated antioxidant actions of pro-electrophilic drugs","volume":"65","author":"Satoh","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2021.120111_bb1005","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/toxsci\/kfu080","article-title":"Chemical tuning enhances both potency toward nrf2 and in vitro therapeutic index of triterpenoids","volume":"140","author":"Copple","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.lfs.2021.120111_bb1010","doi-asserted-by":"crossref","first-page":"104614","DOI":"10.1016\/j.bioorg.2020.104614","article-title":"Discovery and SAR studies of 3-amino-4-(phenylsulfonyl)tetrahydrothiophene 1,1-dioxides as non-electrophilic antioxidant response element (ARE) activators","volume":"108","author":"Jo","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb1015","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.389","article-title":"Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2\/ARE pathway in Alzheimer's disease models","volume":"7","author":"Lipton","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2021.120111_bb1020","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.12688\/f1000research.12111.1","article-title":"Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate","volume":"6","author":"Satoh","year":"2017","journal-title":"F1000Res."},{"key":"10.1016\/j.lfs.2021.120111_bb1025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0165-0173(97)00045-3","article-title":"Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death","volume":"25","author":"Bains","year":"1997","journal-title":"Brain. Res. BrainRes. Rev."},{"key":"10.1016\/j.lfs.2021.120111_bb1030","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/MCB.26.8.2887-2900.2006","article-title":"Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model","volume":"26","author":"Tong","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb1035","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1107\/S0907444905022626","article-title":"Conserved solvent and side-chain interactions in the 1.35 angstrom structure of the kelch domain of Keap1","volume":"61","author":"Beamer","year":"2005","journal-title":"Acta Crystallogr.D Biol. Crystallogr."},{"key":"10.1016\/j.lfs.2021.120111_bb1040","doi-asserted-by":"crossref","first-page":"7511","DOI":"10.1128\/MCB.00753-07","article-title":"Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response","volume":"27","author":"Tong","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb1045","doi-asserted-by":"crossref","first-page":"10837","DOI":"10.1021\/acs.jmedchem.6b00586","article-title":"Discovery and development of kelch-like ECH-associated protein 1. Nuclear factor erythroid 2-related factor 2 (KEAP1:NRF2) protein-protein interaction inhibitors: achievements, challenges, and future directions","volume":"59","author":"Jiang","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb1050","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1747-0285.2011.01240.x","article-title":"Kinetic analyses of Keap1-Nrf2 interaction and determination of the minimal Nrf2 peptide sequence required for Keap1 binding using surface plasmon resonance","volume":"78","author":"Chen","year":"2011","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.lfs.2021.120111_bb1055","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/1087057111430124","article-title":"Optimization of fluorescently labeled Nrf2 peptide probes and the development of a fluorescence polarization assay for the discovery of inhibitors of Keap1-Nrf2 interaction","volume":"17","author":"Inoyama","year":"2012","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.lfs.2021.120111_bb1060","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.freeradbiomed.2011.10.486","article-title":"Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction","volume":"52","author":"Hancock","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2021.120111_bb1065","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1039\/c3ob40249e","article-title":"Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction with improved binding and cellular activity","volume":"11","author":"Hancock","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb1070","doi-asserted-by":"crossref","first-page":"85983","DOI":"10.1039\/C5RA16262A","article-title":"Binding thermodynamics and kinetics guided optimization of potent Keap1-Nrf2 peptide inhibitors","volume":"5","author":"Lu","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.lfs.2021.120111_bb1075","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejmech.2018.01.063","article-title":"Discovery of a Keap1-dependent peptide PROTAC to knockdown tau by ubiquitination-proteasome degradation pathway","volume":"146","author":"Lu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb1080","first-page":"1","article-title":"Engineering a genetically encoded competitive inhibitor of the KEAP1-NRF2 interaction via structure-based design and phage display","volume":"29","author":"Guntas","year":"2016","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.lfs.2021.120111_bb1085","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.ejmech.2017.10.052","article-title":"Discovery of a head-to-tail cyclic peptide as the Keap1-Nrf2 protein-protein interaction inhibitor with high cell potency","volume":"143","author":"Lu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb1090","doi-asserted-by":"crossref","first-page":"115738","DOI":"10.1016\/j.bmc.2020.115738","article-title":"Optimization of linear and cyclic peptide inhibitors of KEAP1-NRF2 protein-protein interaction","volume":"28","author":"Colarusso","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb1095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112532","article-title":"Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors","volume":"202","author":"Mou","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb1100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01208","article-title":"Targeted intracellular delivery of antibodies: the state of the art","volume":"9","author":"Slastnikova","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120111_bb1105","first-page":"95","article-title":"Monobodies: antibody mimics based on the scaffold of the fibronectin type III domain","volume":"352","author":"Koide","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb1110","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jmb.2011.12.019","article-title":"Teaching an old scaffold new tricks: monobodies constructed using alternative surfaces of the FN3 scaffold","volume":"415","author":"Koide","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb1115","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.sbi.2012.06.001","article-title":"Structural insights for engineering binding proteins based on non-antibody scaffolds","volume":"22","author":"Gilbreth","year":"2012","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb1120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0165-6147(00)01447-4","article-title":"Cell-penetrating peptides","volume":"21","author":"Lindgren","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2021.120111_bb1125","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1476-5381.2009.00057.x","article-title":"Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics","volume":"157","author":"Heitz","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120111_bb1130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1021\/ml300041g","article-title":"Anti-inflammatory effect of a cell-penetrating peptide targeting the Nrf2\/Keap1 interaction","volume":"3","author":"Steel","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.lfs.2021.120111_bb1135","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bbrc.2011.03.046","article-title":"A novel strategy to activate cytoprotective genes in the injured brain","volume":"407","author":"Zhao","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2021.120111_bb1140","doi-asserted-by":"crossref","first-page":"14727","DOI":"10.1523\/JNEUROSCI.1304-15.2015","article-title":"Cell-permeable peptide targeting the Nrf2-Keap1 interaction: a potential novel therapy for global cerebral ischemia","volume":"35","author":"Tu","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2021.120111_bb1145","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.8b00358","article-title":"Non-covalent small-molecule kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 (Keap1-Nrf2) inhibitors and their potential for targeting central nervous system diseases","author":"Pallesen","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb1150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ddtec.2017.10.001","article-title":"The Keap1-Nrf2 protein-protein interaction: a suitable target for small molecules","volume":"24","author":"Schmoll","year":"2017","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.lfs.2021.120111_bb1155","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1021\/jm5000529","article-title":"Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis","volume":"57","author":"Jiang","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb1160","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1021\/acs.jmedchem.5b00185","article-title":"Structure-activity and structure-property relationship and exploratory in vivo evaluation of the nanomolar Keap1-Nrf2 protein-protein interaction inhibitor","volume":"58","author":"Jiang","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb1165","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1021\/acs.jmedchem.6b00228","article-title":"Monoacidic inhibitors of the kelch-like ECH-associated protein 1: nuclear factor erythroid 2-related factor 2 (KEAP1:NRF2) protein-protein interaction with high cell potency identified by fragment-based discovery","volume":"59","author":"Davies","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb1170","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.addr.2016.03.013","article-title":"Cell permeability beyond the rule of 5","volume":"101","author":"Matsson","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.lfs.2021.120111_bb1175","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jconrel.2016.02.002","article-title":"Emerging landscape of cell penetrating peptide in reprogramming and gene editing","volume":"226","author":"Liu","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.lfs.2021.120111_bb1180","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.molmed.2012.04.012","article-title":"Cell-penetrating peptides: breaking through to the other side","volume":"18","author":"Koren","year":"2012","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.lfs.2021.120111_bb1185","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.febslet.2013.04.031","article-title":"Cell-penetrating peptides: 20 years later, where do we stand?","volume":"587","author":"Bechara","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2021.120111_bb1190","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1021\/nn4057269","article-title":"Cell-penetrating peptides: design, synthesis, and applications","volume":"8","author":"Copolovici","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.lfs.2021.120111_bb1195","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1074\/jbc.M209548200","article-title":"Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake","volume":"278","author":"Richard","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.120111_bb1200","first-page":"1043","article-title":"Development of p53 protein transduction therapy using membrane-permeable peptides and the application to oral cancer cells","volume":"1","author":"Takenobu","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.lfs.2021.120111_bb1205","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jconrel.2017.11.004","article-title":"Transcription factors: time to deliver","volume":"269","author":"Ulasov","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.lfs.2021.120111_bb1210","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1134\/S0006297920070111","article-title":"Transcription factor Nrf2 as a potential therapeutic target for prevention of cytokine storm in COVID-19 patients","author":"Zinovkin","year":"2020","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.lfs.2021.120111_bb1215","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tips.2020.07.003","article-title":"Can activation of NRF2 be a strategy against COVID-19?","volume":"41","author":"Cuadrado","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2021.120111_bb1220","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev-pharmtox-010818-021118","article-title":"Engineered protein scaffolds as next-generation therapeutics","volume":"60","author":"Gebauer","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.lfs.2021.120111_bb1225","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41594-020-0438-0","article-title":"Targeted protein degradation as a powerful research tool in basic biology and drug target discovery","volume":"27","author":"Wu","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb1230","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ddtec.2018.12.001","article-title":"Monitoring and deciphering protein degradation pathways inside cells","volume":"31","author":"Daniels","year":"2019","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.lfs.2021.120111_bb1235","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nchembio.1858","article-title":"Catalytic in vivo protein knockdown by small-molecule PROTACs","volume":"11","author":"Bondeson","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.lfs.2021.120111_bb1240","first-page":"467","article-title":"Modular nanotransporters: a multipurpose in vivo working platform for targeted drug delivery","volume":"7","author":"Slastnikova","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.lfs.2021.120111_bb1245","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrd4333","article-title":"Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery","volume":"13","author":"Torchilin","year":"2014","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521010985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521010985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:52:02Z","timestamp":1758401522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521010985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":250,"alternative-id":["S0024320521010985"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120111","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nrf2\/Keap1\/ARE signaling: Towards specific regulation","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120111"}}